Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer

Author： Khamly Kenneth   Jefford Michael   Michael Michael   Zalcberg John  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.6, 2005-06, pp. : 607-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New therapy options for advanced colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid

By Sculpher M.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

By Cattel L.   La Grotta G.   Infante L.   Passera R.   Arpicco S.   Brusa P.   Bumma C.  

Il Farmaco, Vol. 58, Iss. 12, 2003-12 ,pp. : 1333-1338

Elsevier

Access to resources Recommend Favorite

Double Biochemical Modulation of 5-Fluorouracil by Methotrexate and Folinic Acid for the Treatment of Advanced Colorectal Cancer

By Polyzos A.   Tsavaris N.   Kosmas C.   Petrikos G.   Stamatiadis D.   Kalahanis N.   Giannopoulos A.   Karatzas G.   Sfikakis P.P.  

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 83-88

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite